Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Home versus in-centre haemodialysis for end-stage kidney disease.

Palmer SC, Palmer AR, Craig JC, Johnson DW, Stroumza P, Frantzen L, Leal M, Hoischen S, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 Nov 20;(11):CD009535. doi: 10.1002/14651858.CD009535.pub2. Review.

PMID:
25412074
2.

High-flux versus low-flux membranes for end-stage kidney disease.

Palmer SC, Rabindranath KS, Craig JC, Roderick PJ, Locatelli F, Strippoli GF.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD005016. doi: 10.1002/14651858.CD005016.pub2. Review.

PMID:
22972082
3.

Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage renal disease in adults.

Vale L, Cody J, Wallace S, Daly C, Campbell M, Grant A, Khan I, Donaldson C, Macleod A.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003963. Review.

4.

Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage renal disease in adults.

Vale L, Cody J, Wallace S, Daly C, Campbell M, Grant A, Khan I, Donaldson C, MacLeod A.

Cochrane Database Syst Rev. 2003;(1):CD003963. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003963.

PMID:
12535493
5.

Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.

MacLeod A, Daly C, Khan I, Vale L, Campbell M, Wallace S, Cody J, Donaldson C, Grant A.

Cochrane Database Syst Rev. 2001;(3):CD003234. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003234.

PMID:
11687058
6.

Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.

Nistor I, Palmer SC, Craig JC, Saglimbene V, Vecchio M, Covic A, Strippoli GF.

Cochrane Database Syst Rev. 2015 May 20;(5):CD006258. doi: 10.1002/14651858.CD006258.pub2. Review.

PMID:
25993563
7.

Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease.

Smart NA, Dieberg G, Ladhani M, Titus T.

Cochrane Database Syst Rev. 2014 Jun 18;(6):CD007333. doi: 10.1002/14651858.CD007333.pub2. Review.

PMID:
24938824
8.

Pre-emptive correction for haemodialysis arteriovenous access stenosis.

Ravani P, Quinn RR, Oliver MJ, Karsanji DJ, James MT, MacRae JM, Palmer SC, Strippoli GF.

Cochrane Database Syst Rev. 2016 Jan 7;(1):CD010709. doi: 10.1002/14651858.CD010709.pub2. Review.

PMID:
26741512
9.

Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients.

Hahn D, Cody JD, Hodson EM.

Cochrane Database Syst Rev. 2014 May 28;(5):CD003895. doi: 10.1002/14651858.CD003895.pub3. Review.

PMID:
24872328
10.

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.

Tanner NC, Da Silva A.

Cochrane Database Syst Rev. 2015 Jul 16;(7):CD002786. doi: 10.1002/14651858.CD002786.pub3. Review.

PMID:
26184395
11.

Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease.

Wang Y, Ivany JN, Perkovic V, Gallagher MP, Woodward M, Jardine MJ.

Cochrane Database Syst Rev. 2016 Apr 4;4:CD009631. doi: 10.1002/14651858.CD009631.pub2. Review.

PMID:
27039404
12.

Immunosuppressive agents for treating IgA nephropathy.

Vecchio M, Bonerba B, Palmer SC, Craig JC, Ruospo M, Samuels JA, Molony DA, Schena FP, Strippoli GF.

Cochrane Database Syst Rev. 2015 Aug 3;(8):CD003965. doi: 10.1002/14651858.CD003965.pub2. Review.

PMID:
26235292
13.

Early versus delayed erythropoietin for the anaemia of end-stage kidney disease.

Coronado Daza J, Martí-Carvajal AJ, Ariza García A, Rodelo Ceballos J, Yomayusa González N, Páez-Canro C, Loza Munárriz C, Urrútia G.

Cochrane Database Syst Rev. 2015 Dec 16;(12):CD011122. doi: 10.1002/14651858.CD011122.pub2. Review.

PMID:
26671531
14.

Dietary interventions for adults with chronic kidney disease.

Palmer SC, Maggo JK, Campbell KL, Craig JC, Johnson DW, Sutanto B, Ruospo M, Tong A, Strippoli GF.

Cochrane Database Syst Rev. 2017 Apr 23;4:CD011998. doi: 10.1002/14651858.CD011998.pub2. Review.

PMID:
28434208
15.

Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis.

Palmer SC, Natale P, Ruospo M, Saglimbene VM, Rabindranath KS, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2016 May 23;(5):CD004541. doi: 10.1002/14651858.CD004541.pub3. Review.

PMID:
27210414
16.

Advance care planning for haemodialysis patients.

Lim CE, Ng RW, Cheng NC, Cigolini M, Kwok C, Brennan F.

Cochrane Database Syst Rev. 2016 Jul 26;7:CD010737. doi: 10.1002/14651858.CD010737.pub2. Review.

17.

Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients.

Montero N, Webster AC, Royuela A, Zamora J, Crespo Barrio M, Pascual J.

Cochrane Database Syst Rev. 2014 Sep 15;(9):CD007669. doi: 10.1002/14651858.CD007669.pub2. Review.

PMID:
25220222
18.

HMG CoA reductase inhibitors (statins) for dialysis patients.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2013 Sep 11;(9):CD004289. doi: 10.1002/14651858.CD004289.pub5. Review.

PMID:
24022428
19.

Acupuncture and related interventions for symptoms of chronic kidney disease.

Kim KH, Lee MS, Kim TH, Kang JW, Choi TY, Lee JD.

Cochrane Database Syst Rev. 2016 Jun 28;(6):CD009440. doi: 10.1002/14651858.CD009440.pub2. Review.

PMID:
27349639
20.

Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units.

Bravo Zuñiga JI, Loza Munárriz C, López-Alcalde J.

Cochrane Database Syst Rev. 2016 Aug 11;(8):CD006420. doi: 10.1002/14651858.CD006420.pub2. Review.

PMID:
27513591

Supplemental Content

Support Center